On Jan 5, 2022 Korro Bio closed a Series B round and raised $116,000,000 from Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset Management, Fidelity Management and Research Company, Invus, Monashee Investment Management, MP Healthcare Venture Management, New Enterprise Associates, Point72, Qiming Venture Partners USA, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital, featuring lead investors Eventide Asset Management.

About the company: Korro Bio is located at United States, North America.
“”

Company website: http://www.korrobio.com